CIK 0001504776
- Large accelerated filer
Warby Parker Inc.
Sign in to watch- Ticker
- WRBY
- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800423634
- Phone
- +1 646-847-7215
- Business address
- 233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
- Former names
- JAND, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,861,485
- in 5 filings, $7.9M under 10b5-1 plans
Net −$7,861,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-08 | Gilboa David Abraham Co-Chief Executive Office | Exercise or conversion · Restricted Stock Units | −84,295 | 843,987 | ||
| 2023-12-08 | Gilboa David Abraham Co-Chief Executive Office | Exercise or conversion · Class B Common Stock | +93,171 | 6,699,984 | ||
| 2023-12-08 | Gilboa David Abraham Co-Chief Executive Office | Conversion · Class B Common Stock | −56,038 | 6,643,946 | ||
| 2023-12-08 | Miller Steven Clive Chief Financial Officer | Exercise or conversion 10b5-1 | +18,480 | 207,064 | ||
| 2023-12-08 | Miller Steven Clive Chief Financial Officer | Sale 10b5-1 | −7,760 | $10.56 | $82K | 199,304 |
| 2023-12-08 | Miller Steven Clive Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,981 | 9,245 | ||
| 2023-12-08 | Miller Steven Clive Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −2,525 | 1,684 | ||
| 2023-12-08 | Miller Steven Clive Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −5,095 | 33,973 | ||
| 2023-12-08 | Miller Steven Clive Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −8,879 | 112,477 | ||
| 2023-09-08 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion | +5,016 | 5,122 | ||
| 2023-09-08 | Blumenthal Neil Harris Co-Chief Executive Officer | Sale | −5,016 | $11.92 | $60K | 106 |
| 2023-09-08 | Blumenthal Neil Harris Co-Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −4,545 | 7,717 | ||
| 2023-09-08 | Blumenthal Neil Harris Co-Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −4,332 | 24,403 | ||
| 2023-09-08 | Blumenthal Neil Harris Co-Chief Executive Officer | Exercise or conversion · Class B Common Stock | +8,877 | 4,220,770 | ||
| 2023-09-08 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion · Class B Common Stock | −5,016 | 4,215,754 | ||
| 2023-09-08 | Briggs Teresa Director | Exercise or conversion | +2,149 | 15,969 | ||
| 2023-09-08 | Briggs Teresa Director | Exercise or conversion · Restricted Stock Unit | −2,149 | 0 | ||
| 2023-09-08 | Miller Steven Clive Chief Financial Officer | Exercise or conversion | +18,482 | 194,859 | ||
| 2023-09-08 | Miller Steven Clive Chief Financial Officer | Sale | −7,607 | $11.92 | $91K | 187,252 |
| 2023-09-08 | Miller Steven Clive Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −1,981 | 11,226 |
Page 25 of 59 · 1,167 trades